Svein Skeie

Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart

P Vague, Jean-Louis Sélam, Svein Skeie et al. · Diabetes Care · 2003 · 294 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Insulin detemir used in basal‐bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

I. De Leeuw, P Vague, J. L. Selam et al. · Diabetes Obesity and Metabolism · 2004 · 179 citations

Medicine, Endocrinology, Internal Medicine +16

Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease

BG Nedrebo, PI Holm, Sverre Uhlving et al. · European Journal of Endocrinology · 2002 · 132 citations

Pharmacy, Endocrinology, Pharmacotherapy +13

Instruments for Self-Monitoring of Blood Glucose: Comparisons of Testing Quality Achieved by Patients and a Technician

Svein Skeie, Geir Thue, Kari Nerhus et al. · Clinical Chemistry · 2002 · 131 citations · Full text

Medicine, Internal Medicine, Diabetology +16

Severity and duration of diabetic foot ulcer (DFU) before seeking care as predictors of healing time: A retrospective cohort study

Hilde Smith‐Strøm, Marjolein M. Iversen, Jannicke Igland et al. · PLoS ONE · 2017 · 124 citations · Full text

Medicine, Surgery, Clinical Epidemiology +14